Chairs: Chantal Mathieu (BEL) & Zoe Williams (GBR)
| 09:00 – 09:15 | Welcome and introduction: intergrating a person-centred approach to cardimetabolic diseases | Chantal Mathieu (BEL) Zoe Williams (GBR) |
| 09:15 – 09:35 | Broading personal choice in obesity care: injectable and oral semaglutide formulations | Carel Le Roux (IRL) |
| 09:35 – 09:55 | Raising the bar in T2D care: optimising glucose and weight management with semaglutide | Harpreet Bajaj (CAN) |
| 09:55 – 10:10 | Ahead of the curve: early intervention in obesity strategies for children and adolescents | Martin Wabitsch (GER) |
| 10:10 – 10:20 | Panel discussion | Carel Le Roux (IRL) |
| 10:20 – 10:40 | Coffee break | |
| 10:40 – 10:45 | Welcome back | Chantal Mathieu (BEL) Zoe Williams (GBR) |
| 10:45 – 11:55 | Semaglutide in holistic cardiometabolic care: beyond glycaemia and weight | Katherine Tuttle (USA) |
| 11:55 – 12:00 | Session close | Chantal Mathieu (BEL) Zoe Williams (GBR) |
| 12:00 – 12:45 | Lunch break | |
| 12:45 – 12:50 | Amylin in focus: framing the scientific journey ahead | Chantal Mathieu (BEL) Zoe Williams (GBR) |
| 12:50 – 13:10 | Amylin: from physiological insights to therapeutic potential | Anna Secher (DNK) |
| 13:10 – 14:05 | CagriSema: releasing the power of amylin in obesity and T2D | Kirsi Pietiläinen (FIN) John Buse (USA) |
| 14:05 – 14:25 | Expert perspectives: the potential of amylin-based therapies | Kirsi Pietiläinen (FIN) |
| 14:25 – 14:55 | Zenagamtide: GLP-1 and amylin agonism in one molecule | Roopa Mehta (MEX) Pablo Mora (USA) |
| 14:55 – 15:05 | Expert perspectives: future directions | Roopa Mehta (MEX) Pablo Mora (USA) |
| 15:05 – 15:15 | Looking ahead: the future of amylin in metabolic disease | Chantal Mathieu (BEL) Zoe Williams (GBR) |
| 15:15 – 15:45 | Coffee break | |
| 15:45 | Monday to Monday: the once-weekly mindset with insulins | Concetta Irace (ITA) Harpreet Bajaj (CAN) |
| 15:45 | Evidence in context: the potential of amylin-based therapies | Pablo Mora (USA) John Buse (USA) |
| 15:45 | From data to decision-making: practical considerations for GLP-1 therapy | Carel Le Roux (IRL) Roopa Mehta (MEX) |
- Monday, 28 September 2026
- 09:00 - 16:30 CEST
- Milan Hall